Humacyte (HUMA) Earnings Analysis

Humacyte (HUMA) next reports earnings on 2026-08-10, consensus EPS -0.1 USD. Last quarter (2026-03-27) it beat with EPS -0.13 USD vs -0.13 USD est (0%). It has beaten estimates in 2/4 recent quarters (50%). Trailing P/E -1.09.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does HUMA next report earnings?

Next earnings date2026-08-10
Consensus EPS estimate-0.1 USD
Revenue estimate0.00B

HUMA earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-03-27-0.13 USD-0.13 USD0%Beat
2025-11-12-0.14 USD-0.17 USD+17.6%Beat
2025-08-11-0.24 USD-0.15 USD-60%Miss
2024-11-08-0.33 USD-0.26 USD-26.9%Miss

Beat rate: 2/4 (50%) over reported quarters with consensus data.

HUMA valuation and analyst view

Trailing P/E-1.09
Trailing EPS-0.49327 USD
Price / book10.97
Dividend yield0.00%
Market cap0.11B
Analyst consensusBuy (10 buy / 1 hold / 0 sell)
Avg price target4.17 USD

Related research pages

Frequently asked questions

When is Humacyte (HUMA)'s next earnings date?

Humacyte is next scheduled to report on 2026-08-10, with a consensus EPS estimate of -0.1 USD and revenue estimate of 0.00B.

Did HUMA beat earnings last quarter?

In its 2026-03-27 report, HUMA posted EPS of -0.13 USD versus a -0.13 USD estimate — a beat of 0%.

What is HUMA's earnings track record?

Over the last 4 reported quarters with consensus data, HUMA beat estimates 2 times (50%).

What is HUMA's current P/E ratio and EPS?

HUMA trades at a trailing P/E of -1.09 on trailing EPS of -0.49326553123789435 USD.

What do analysts rate HUMA?

Analyst consensus is "Buy" across 11 ratings (0 strong buy, 10 buy, 1 hold, 0 sell, 0 strong sell). Average 12-month price target: 4.17 USD.